JP2006506948A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506948A5
JP2006506948A5 JP2003584268A JP2003584268A JP2006506948A5 JP 2006506948 A5 JP2006506948 A5 JP 2006506948A5 JP 2003584268 A JP2003584268 A JP 2003584268A JP 2003584268 A JP2003584268 A JP 2003584268A JP 2006506948 A5 JP2006506948 A5 JP 2006506948A5
Authority
JP
Japan
Prior art keywords
raav
composition
scfvx5
igg1b12
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003584268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506948A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/010865 external-priority patent/WO2003087324A2/en
Publication of JP2006506948A publication Critical patent/JP2006506948A/ja
Publication of JP2006506948A5 publication Critical patent/JP2006506948A5/ja
Withdrawn legal-status Critical Current

Links

JP2003584268A 2002-04-09 2003-04-09 抗体遺伝子送達およびそのための組換えａａｖ Withdrawn JP2006506948A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37150102P 2002-04-09 2002-04-09
PCT/US2003/010865 WO2003087324A2 (en) 2002-04-09 2003-04-09 Antibody gene transfer and recombinant aav

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009238783A Division JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Publications (2)

Publication Number Publication Date
JP2006506948A JP2006506948A (ja) 2006-03-02
JP2006506948A5 true JP2006506948A5 (https=) 2006-07-06

Family

ID=29250690

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003584268A Withdrawn JP2006506948A (ja) 2002-04-09 2003-04-09 抗体遺伝子送達およびそのための組換えａａｖ
JP2009238783A Pending JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009238783A Pending JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Country Status (6)

Country Link
US (3) US20030219733A1 (https=)
EP (3) EP2278020A3 (https=)
JP (2) JP2006506948A (https=)
AU (1) AU2003223517A1 (https=)
CA (1) CA2481813A1 (https=)
WO (1) WO2003087324A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070041943A1 (en) * 2004-12-29 2007-02-22 Children's Hospital Research Expression of virus entry inhibitors and recombinant AAV thereof
US9725485B2 (en) 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
US9611302B2 (en) 2007-04-09 2017-04-04 University Of Florida Research Foundation, Inc. High-transduction-efficiency RAAV vectors, compositions, and methods of use
DK2191001T3 (en) 2007-04-09 2016-09-19 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
EP2910637A1 (en) 2008-05-20 2015-08-26 University of Florida Research Foundation, Inc. Vectors for delivery of light-sensitive proteins and methods of use
EP2172481B1 (en) * 2008-10-06 2014-10-29 Novoplant GmbH Proteolytically stable antibody formats
WO2010040545A1 (en) * 2008-10-06 2010-04-15 Novoplant Gmbh Proteolytically stable antibody formats
US8865881B2 (en) 2011-02-22 2014-10-21 California Institute Of Technology Delivery of proteins using adeno-associated virus (AAV) vectors
CN102634542B (zh) * 2012-04-12 2014-03-26 北京工业大学 一种表达人抗体全基因的重组腺相关病毒(rAAV)载体及其方法
US10294281B2 (en) 2012-05-15 2019-05-21 University Of Florida Research Foundation, Incorporated High-transduction-efficiency rAAV vectors, compositions, and methods of use
US12358954B2 (en) 2012-05-15 2025-07-15 University Of Florida Research Foundation, Incorporated Capsid-modified rAAV vector compositions and methods therefor
CN102690842B (zh) * 2012-06-12 2014-04-23 北京工业大学 一种表达人抗体全基因的重组腺病毒(rAdv)载体及其方法
CA2886161A1 (en) 2012-09-29 2014-04-03 The Trustees Of The University Of Pennsylvania Veterinary composition and methods for non-surgical neutering and castration
GB201308658D0 (en) * 2013-05-14 2013-06-26 Isis Innovation Antibodies
WO2016126857A1 (en) 2015-02-03 2016-08-11 University Of Florida Research Foundation, Inc. Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
EP3448987A4 (en) * 2016-04-29 2020-05-27 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
FR3080621B1 (fr) * 2018-04-26 2022-12-09 Univ Limoges Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde
KR20220012231A (ko) * 2019-04-24 2022-02-03 리젠엑스바이오 인크. 완전-인간 번역 후 변형된 항체 치료제
WO2020227515A1 (en) 2019-05-07 2020-11-12 Voyager Therapeutics, Inc. Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
IL301131A (en) * 2020-09-09 2023-05-01 Homology Medicines Inc Vector antibodies and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US371501A (en) 1887-10-11 Disteict
US20020159979A1 (en) * 1994-06-06 2002-10-31 Children's Hospital, Inc. Adeno-associated virus materials and methods
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
CA2303768C (en) * 1997-09-19 2009-11-24 The Trustees Of The University Of Pennsylvania Methods and vector constructs useful for production of recombinant aav
US6953690B1 (en) * 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
US6358511B1 (en) * 1998-05-04 2002-03-19 Mount Sinai School Of Medicine Of The City University Of New York Inhibitors of HIV infection
WO2001059142A1 (en) * 2000-02-09 2001-08-16 Medimmune, Inc. Antibody gene therapy with adeno-associated viral vectors
ATE481109T1 (de) * 2001-10-16 2010-10-15 Us Gov Health & Human Serv Neutralisierende antikörper gegen hiv mit breiter kreuzreaktion, die mit hilfe von env-cd4-co- rezeptorkomplexen selektiert werden
US20070041943A1 (en) * 2004-12-29 2007-02-22 Children's Hospital Research Expression of virus entry inhibitors and recombinant AAV thereof

Similar Documents

Publication Publication Date Title
JP2006506948A5 (https=)
JP2009268467A5 (https=)
JP2005537211A5 (https=)
ATE497974T1 (de) Multifunktionelle cytokine
JP2005120106A5 (https=)
WO2002078524A3 (en) Translational profiling
DE60125381D1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
JP2006516189A5 (https=)
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
IL177230A0 (en) Amylin family peptides and methods for making and using them
DE60142922D1 (de) Für antigene polypeptide des hiv type c kodierende nukleinsäuren, entsprechende polypeptide und verwendungen davon
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
HRP20140888T1 (hr) Humana monoklonalna protutijela za humani il-4
NO20063374L (no) Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger
WO2003008449A8 (en) Ntb-a, a surface molecule involved in natural killer cells activity
WO2008133141A1 (ja) オスモチン組換えタンパク質およびその製造方法、並びにその利用
WO2008041863A8 (en) Novel genes and polypeptides associated with insecticidal activity
JP2006506332A5 (https=)
JP2004532037A5 (https=)
WO2002081623A3 (en) Cell cycle nucleic acids, polypeptides and uses thereof
ATE403007T1 (de) Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen
GB9916703D0 (en) Viral protein binding compositions and methods
DE602005010874D1 (en) Polypeptid
NO20075070L (no) rekombinant E-selektin fremstilt i insektceller
JP2003522157A5 (https=)